{"id":100,"date":"2014-11-06T10:47:19","date_gmt":"2014-11-06T10:47:19","guid":{"rendered":"http:\/\/delveinsightblog.wordpress.com\/?p=100"},"modified":"2021-07-24T12:56:20","modified_gmt":"2021-07-24T07:26:20","slug":"api-manufacturers-across-the-globe-market-intelligence-report","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/api-manufacturers-across-the-globe-market-intelligence-report","title":{"rendered":"API Manufacturers Across the Globe: Market Intelligence Report"},"content":{"rendered":"

The\u00a0<\/span>Active Pharmaceutical Ingredients<\/strong>\u00a0<\/span>worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.\u00a0<\/span><\/p>\n

DelveInsight API Insights<\/strong>\u2019 focus uncovers the commercial manufacturing status of 1600 Active Pharmaceutical ingredient molecules and above. The Report opens the opportunities for Generic Industries, Drug Companies as well as API Manufacturers to keep them updated on the API front all across the globe. \u00a0The data in the report will provide you with the strategic move for long term successful business.<\/p>\n

DelveInsight<\/strong><\/p>\n

DelveIns<\/em>ight is serving thousands of Companies and associated people i<\/em>n decision making in this highly competitive world.<\/em><\/p>\n

Ph<\/strong>arm API <\/strong><\/p>\n

Get the best out of Pharm API. Pharm API <\/em>guides you at every step of the <\/em>API buisness leading to successful milestones<\/em>.<\/em><\/strong><\/p>\n

Repo<\/strong>rt Prices<\/strong><\/p>\n

Drug Reports starts from USD 500 <\/span><\/em>
\nIndication Reports starts fro<\/em>m USD 1250<\/span><\/em><\/p>\n

API IN<\/strong>SIGH<\/strong>TS<\/strong><\/p>\n

The USDMF and EUDMF filings are the only way for API Manufacturers to take out the business in US and Europe countries. The US and EU5 with a strong business in Pharmaceutical Market provides an indication of which API manufacturers have an interest in penetrating the respective market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently followed by Italy and Spain.<\/div>\n
<\/div>\n
<\/div>\n

Strategic Advantage\u00a0<\/span>
\n<\/strong><\/p>\n